Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Prepaid Assets (2013 - 2026)

Scynexis' (SCYX) quarterly Prepaid Assets came in at $1.5 million in Q2 2026, down 2.41% on a YoY basis from $1.6 million in Q2 2025, and up 67.57% quarter-over-quarter from $919000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Prepaid Assets (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Prepaid Assets for 14 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 2.41% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.5 million (down 2.41% YoY), and the FY2025 full-year result was $263000.0, down 87.96% from the prior year.
  • Prepaid Assets advanced to $1.5 million in Q2 2026 per SCYX's latest filing, from $919000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.5 million in Q4 2023 and bottomed at $263000.0 in Q4 2025.
  • Historically, Prepaid Assets has averaged $2.3 million across 5 years, with a median of $1.7 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets surged 121.65% in 2023, then plunged 87.96% in 2025.
  • Over 5 years, Prepaid Assets stood at $2.5 million in 2022, then soared by 121.65% to $5.5 million in 2023, then plunged by 60.63% to $2.2 million in 2024, then slumped by 87.96% to $263000.0 in 2025, then surged by 485.55% to $1.5 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.5 million, $919000.0, and $263000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Mn
Mar 31, 2026 919,000.00
Dec 31, 2025 263,000.00
Sep 30, 2025 686,000.00
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.45 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.42 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 5.55 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 2.67 Mn
Mar 31, 2023 1.73 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 4.14 Mn
Jun 30, 2022 4.15 Mn
Mar 31, 2022 3.92 Mn
Dec 31, 2021 3.57 Mn
Sep 30, 2021 3.16 Mn